Bio-Rad Laboratories Class A
216 hedge funds and large institutions have $2.87B invested in Bio-Rad Laboratories Class A in 2014 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 70 reducing their positions, and 17 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
36% more capital invested
Capital invested by funds: $2.1B → $2.87B (+$765M)
8% more funds holding
Funds holding: 200 → 216 (+16)
6% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 70
0.74% more ownership
Funds ownership: 78.4% → 79.14% (+0.74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
+$27.2M |
| 2 |
Select Equity Group
New York
|
+$23.6M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$15.5M |
| 4 |
TM
Tikvah Management
Charlotte,
North Carolina
|
+$11M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$68.3M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$22.6M |
| 3 |
RA
Royce & Associates
New York
|
-$14M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$9.28M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$5.82M |
BIO Hedge Fund Activity: Q4 2014 in Review
216 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2014, worth a combined $2.87B — up 36% from $2.1B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new BIO positions and 17 closed out — a net gain of 19 holders — while 74 added to existing stakes and 70 trimmed.
The largest buyer was Gotham Asset Management, adding an estimated $27.2M. The largest seller was Champlain Investment Partners, cutting an estimated $68.3M.
- 216 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2014, up from 200 in Q3 2014.
- Funds reported $2.87B of Bio-Rad Laboratories Class A stock for Q4 2014, up 36% quarter-over-quarter.
- 36 funds opened new Bio-Rad Laboratories Class A positions in Q4 2014 and 17 closed out, a net change of +19 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2014 was Gotham Asset Management, an estimated $27.2M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2014 was Champlain Investment Partners, an estimated $68.3M sold.
Based on aggregated 13F filings for Q4 2014.